News Medical group advises against leucovorin for autism The American Academy of Paediatrics has warned against leucovorin as a treatment for autism, citing a lack of evidence on safety and efficacy.
News "Significant shift" as NICE widens prostate cancer drug use NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market.
News As UK mulls prostate cancer screening, study shows benefit New data have shown that the balance between the benefits and harms of prostate cancer screening has improved with longer follow-up.
News Falling flu vaccine sales in US stall CSL's Seqirus spinout CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.
News Texas sues J&J, Kenvue over Tylenol autism claim Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.
News Campaign seeks to plug HIV care gap for UK women ViiV's campaign wants communication between women and healthcare workers about HIV to move beyond harmful stereotypes and 'risk' labels.
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.